Caplacizumab
Drug
>
![PDF] Caplacizumab as an emerging treatment option for acquired ...](/imgres?imgurl=https://d3i71xaburhd42.cloudfront.net/859edbfb4ed400021803b43afe73550f60855266/2-Figure1-1.png&imgrefurl=https://www.semanticscholar.org/paper/Caplacizumab-as-an-emerging-treatment-option-for-Elverdi-E%25C5%259Fkazan/859edbfb4ed400021803b43afe73550f60855266&h=552&w=1352&tbnid=IWPx4xeO-Mc-yM&q=Caplacizumab&tbnh=61&tbnw=150&usg=AI4_-kQYldm3p8NrscX3xd9kx20WfANbZg&vet=1&docid=BcmQHYwLAdYZCM&sa=X&ved=2ahUKEwiK3K2V3aCGAxXe4ckDHQdCDuUQ9QF6BAgAEAQ)
Caplacizumab is a bivalent single-domain antibody designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis.
This drug was developed by Ablynx NV. Wikipedia
ATC code: B01AX07 (WHO)
Other names: ALX-0081, caplacizumab-yhdp
Learn What To Expect When Getting Started With CABLIVI®. See Helpful Info Here. See Clinical Data For CABLIVI®...